Non-small cell lung cancer

Combination Immunotherapy More Effective in Neoadjuvant NSCLC
News & Features

Combination Immunotherapy More Effective in Neoadjuvant NSCLC

Chris Anderson -
0
Charging to the Frontline
News & Features

Charging to the Frontline

Chris Anderson -
0
Lilly’s Retevmo Beats PD-1 Combo for RET Fusion-Positive Lung Cancer
News & Features

Lilly’s Retevmo Beats PD-1 Combo for RET Fusion-Positive Lung Cancer

Alisa Kirkin -
0
Leveraging the Full Potential of Sensitive Circulating Tumor DNA Analyses
News & Features

Leveraging the Full Potential of Sensitive Circulating Tumor DNA Analyses

Kathy Vuksanaj -
0
Protein Uncovered Implicated in Lung Cancer Resistance to TKIs
News & Features

Protein Uncovered Implicated in Lung Cancer Resistance to TKIs

Chris Anderson -
0
First-line Atezolizumab Improves Survival in Platinum-Ineligible NSCLC
News & Features

First-line Atezolizumab Improves Survival in Platinum-Ineligible NSCLC

Chris Anderson -
0
AZ’s Antibody Drug Conjugate Candidate Meets PFS Endpoint in NSCLC Phase III Trial
News & Features

AZ’s Antibody Drug Conjugate Candidate Meets PFS Endpoint in NSCLC Phase III Trial

Chris Anderson -
0
Diet May Have Big Effect on Common Lung Cancer Treatment
News & Features

Diet May Have Big Effect on Common Lung Cancer Treatment

Malorye Branca -
0
Real-World Data Reassure Advanced NSCLC Patients Stopping Immunotherapy at Two years
News & Features

Real-World Data Reassure Advanced NSCLC Patients Stopping Immunotherapy at Two years

Kathy Vuksanaj -
0
Tagrisso Doubles Survival Rate in EGFR Positive Lung Cancer
Molecular Dx

Tagrisso Doubles Survival Rate in EGFR Positive Lung Cancer

Malorye Branca -
0
123...8Page 1 of 8

Related Content

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine